Ghana

in page functions
[French]
Ghana
Total population (2017) 28,656,712
Birth cohort (2017) 890,884
Surviving Infants (surviving to 1 year per year, 2017) 848,786
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 43/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 62/1000
World Bank Index, IDA (2015) 3.57
Gross Nation Income (per capita US$, 2015) 1,480
Co-financing group (2017) Accelerated transition
No. of districts/territories (2016) 216

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Ghana

Type of support

Approvals

2001-2021 (US$)
(23 Aug 2017)

Commitments

2001-2021 (US$)
(23 Aug 2017)

Disbursements

2000-2017 (US$)
(23 Aug 2017)

% Disbursed

(23 Aug 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $265,622,333 $281,047,983 $263,014,580
Cash Support (CASHSUPP) $170,000 $195,000 $170,000 100%
Civil Society Organisation support (CSO) $765,000 $765,000 $832,909 109%
Health system strengthening (HSS 1) $9,670,000 $9,670,000 $9,670,000 100%
Health system strengthening (HSS 2) $11,179,146 $18,059,296 $7,739,496 69%
HPV Demo (NVS) $188,885 $188,885 $190,108 101%
Immunisation services support (ISS) $5,316,620 $5,316,620 $5,316,620 100%
Injection Safety Devices (NVS) $462,500 $829,000 $587,102 127%
Injection safety support (INS) $855,300 $855,300 $855,300 100%
IPV (NVS) $54,268 $54,268 $54,268 100%
Measles (NVS) $1,711,336 $1,711,336 $1,711,336 100%
Measles-Rubella (NVS) $7,750,269 $7,750,269 $7,750,269 100%
Meningitis A (NVS) $1,078,048 $2,351,548 $1,179,816 109%
Meningitis A - campaign (NVS) $2,037,743 $2,037,743 $2,037,743 100%
Meningitis A - mini catch-up campaign (NVS) $635,266 $635,266 $635,266 100%
Meningitis A - mini catch-up op.costs (OPC) $524,500 $524,500 $524,500 100%
Meningitis A - operational costs (OPC) $1,949,753 $1,949,753 $1,949,753 100%
MR - Operational costs (OPC) $7,522,000 $7,522,000 $7,522,000 100%
Penta (NVS) $95,644,272 $100,614,272 $96,494,583 101%
Pneumo (NVS) $79,702,070 $79,702,070 $80,485,450 101%
Rotavirus (NVS) $23,783,350 $23,783,350 $22,482,161 95%
Vaccine Introduction Grant (VIG) $3,448,500 $3,448,500 $3,448,500 100%
Yellow Fever (NVS) $11,173,507 $13,084,007 $11,377,400 102%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Ghana DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 93%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2013) 86.80%
Household survey: DTP3 coverage for female (2013) 90.30%
Household survey: Last DTP3 survey (2013) 89%
% districts achieving > 80% DTP3 coverage (2016) 87%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 89%

Breakdown of support

Non-vaccine support Vaccine support
14% 86%
$38,029,078 $224,985,502

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Ghana

23 May 2017

Seth Q&A

Big Ideas: Gavi CEO Seth Berkley’s Q&A, Part II

Ahead of Seth Berkley’s speech to the 2017 graduating class at Johns Hopkins University in Washington, DC on 23 June, Global Health published a two-part Q&A with the Gavi CEO. In this second article, Seth shares his concerns about the expansion of the vaccine hesitancy movement, explains why digital identity technologies in low- and middle-income countries can help improve vaccine coverage, and discusses the value of testing the potentially important malaria vaccine.

24 April 2017

Mosquito malaria

Partnership supports launch of malaria vaccine pilots in three African countries

Funders hail next step in the development of world’s first malaria vaccine.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

close icon

modal window here